Trelanserin

DB18793InvestigationalSmall molecule

Trelanserin: Overview.

Mechanism: Pharmacologically active on 5-hydroxytryptamine receptor 2A and 5-hydroxytryptamine receptor 1B
Curator reviewed
Formula / weight: C₂₄H₂₄FN₅O₂S · 465.55 g/mol (avg)
Code names: SL-650472

Resolves to

Compound

Structure

InChIKeyJDLYOFUDIKMYBL-UHFFFAOYSA-NSMILESNC(=O)CN1C(=O)C=C(CCN2CCN(CC2)C2=C3C=CSC3=CC=N2)C2=CC=C(F)C=C12

Targets

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Trelanserin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.